Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Costimulation Blockade with VIB4920 and Belatacept in Kidney Transplant
NCT04046549Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2019
- Primary completion
- Jul 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of dazodalibep in kidney transplant rejection, sponsored by Amgen. Started Oct 2019; status: completed.
02
Drugs
dazodalibep
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT04046549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046549.